The DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Somatic mitochondrial DNA mutations in cortex and substantia nigra in aging and Parkinson’s disease
Abstract
Oxidative damage to mitochondrial DNA (mtDNA) increases with age in the brain and can induce G:C to T:A and T:A to G:C point mutations. Though rare at any particular site, multiple somatic mtDNA mutations induced by oxidative damage or by other mechanisms may accumulate with age in the brain and thus could play a role in aging and neurodegenerative diseases. However, no prior study has quantified the total burden of mtDNA point mutation subtypes in the brain. Using a highly sensitive cloning and sequencing strategy, we find that the aggregate levels of G:C to T:A and T:A to G:C transversions and of all point mutations increase with age in the frontal cortex (FCtx). In the substantia nigra (SN), the aggregate levels of point mutations in young controls are similar to the levels in the SN or FCtx of elderly subjects. Extrapolation from our data suggests an average of 2.7 (FCtx) to 3.2 (SN) somatic point mutations per mitochondrial genome in elderly subjects. There were no significant differences between Parkinson's disease (PD) patients and age-matched controls in somatic mutation levels. These results indicate that individually rare mtDNA point mutations reach a high aggregate burden in FCtx and SN of elderly subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We also identified high levels of somatic mtDNA point mutations in elderly PD patients20.”
From Mitochondrial Approaches for Neuroprotection (2008) · cites this paper as [20]
Citations
Cites
Sequence and organization of the human mitochondrial genome
Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H. L., Coulson, A. R., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., et al. (1981) · Nature · doi:10.1038/290457a0 · Cited by 9,740
Oxidants, antioxidants, and the degenerative diseases of aging.
Ames, B. N., Shigenaga, M. K., & Hagen, T. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.17.7915 · Cited by 5,958
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Chronic systemic pesticide exposure reproduces features of Parkinson's disease
Betarbet, R. S., Sherer, T., MacKenzie, G. M., Garcia‐Osuna, M., Panov, A. V., & Greenamyre, J. T. (2000) · Nature Neuroscience · doi:10.1038/81834 · Cited by 3,770
Mitochondrial Complex I Deficiency in Parkinson's Disease
Schapira, A. H. V., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., & Marsden, C. D. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb02325.x · Cited by 2,283
8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions.
Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., & Loeb, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48474-8 · Cited by 1,844
The substantia nigra of the human brain
Damier, P., Hirsch, É. C., Agid, Y., & Graybiel, A. M. (1999) · Brain · doi:10.1093/brain/122.8.1437 · Cited by 1,827
MITOCHONDRIAL COMPLEX I DEFICIENCY IN PARKINSON'S DISEASE
Schapira, A. H. V., Cooper, J. A. D., Dexter, D. T., Jenner, P. G., Clark, J. B., & MARSDEN, C. D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92366-0 · Cited by 1,757
Normal oxidative damage to mitochondrial and nuclear DNA is extensive.
Richter, C., Park, J. W., & Ames, B. N. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6465 · Cited by 1,730
Kasai, H. (1997) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(97)00035-5 · Cited by 1,157
Research works printed but not linked: 2
- Chen, 1994, Evidence for impairment of energy metabolism in Parkinson’s disease using in vivo localized MR spectroscopy, Proc. Soc. Mag. Res., 1, 194
- Sanchez-Ramos, 1994, A marker of oxyradical-mediated DNA damage (8-hydroxy-2′-deoxyguanosine) is increased in nogr-striatum of Parkinson’s disease, Neurodegeneration, 3, 197
Cited by
Sorted by citations
Items 101–118 of 118
The Consequences of Damaged Mitochondrial DNA
Zuo, L., Zhou, T., & Chuang, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-42139-1_3 · Cited by 1
Mitochondria in aging: A review of structure, function, and interorganelle relationships
Chen, M. (2024) · Theoretical and Natural Science · doi:10.54254/2753-8818/29/20240749 · Cited by 1
Apoptosis in Neurodegenerative Diseases
Liang, Q., & Zhang, J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-381-7_21 · Cited by 1
Golden, T. R., Morten, K., Johnson, F., Samper, E., & Melov, S. (2005) · Elsevier eBooks · doi:10.1016/b978-012088387-5/50008-x · Cited by 1
Mitochondrial Manipulation as a Treatment for Aging
Smigrodzki, R. M., & Portell, F. R. (2010) · Springer eBooks · doi:10.1007/978-90-481-3999-6_16 · Cited by 1
ALEXEYEV, M. F., LeDoux, S. P., & Wilson, G. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012369391-4/50042-4 · Cited by 1
(2004) · Rejuvenation Research · doi:10.1089/154916804323105134 · Cited by 1
Wei, W., Keogh, M. J., Ironside, J. W., & Chinnery, P. F. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0434-8
Roy, N. (2015) · KU ScholarWorks (University of Kansas)
Neurodegenerative Disorders Progression
Kaur, R., Kaur, H., Rajput, R., Kumar, S., Rachana, R., & Singh, M. (2018) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/978-1-5225-5282-6.ch006
LFMD: detecting low-frequency mutations in high-depth genome sequencing data without molecular tagsPreprint
Ye, R., Zhuang, X., Ruan, J., Qi, Y.-W., An, Y., Xu, J., Mak, T., Liu, X., Zhang, X.-Q., Yang, H.-M., et al. (2019) · bioRxiv · doi:10.1101/617381
(2012) · Annals of Neurology · doi:10.1002/ana.23649
Peroxisome Proliferator-Activated Receptors: A New Ray Of Hope For Parkinson’s Disease
(2021) · American Journal Of Pharmacy And Health Research · doi:10.46624/ajphr.2021.v9.i9.003
Charnolosome in Parkinson's disease
SHARMA, S. K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-21752-4.00043-2
Ghosh, A. (2012) · Iowa State University Digital Repository (Iowa State University) · doi:10.31274/etd-180810-1769
Bilirubin in Parkinson’s disease: pathogenic mechanisms and therapeutic potentials
Wan, Y., Xie, C., Wang, Q., & Wang, X. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1806875
Metadata
- Authors
- Simon, D. K., Lin, M. T., Zheng, L., Liu, G.-J., Ahn, C. H., Kim, L. M., Mauck, W. M., Twu, F., Beal, M. F., & Johns, D. R.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Cornell University (US)
- Corresponding author
- Simon, David K
- Venue
- Neurobiology of Aging
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 25
- Issue
- 1
- Pages
- 71-81
- ISSN
- 0197-4580 (ISSN-L)
- OpenAlex
- W2075132953
- Cited by
- 118
- References
- 64
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 3 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 4 · 2019: 5 · 2018: 6 · 2017: 4 · 2016: 6 · 2015: 7 · 2014: 5 · 2013: 3 · 2012: 8
- FWCI
- 2.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurobiology of Aging (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k24ns002239-05, 5k08ns001971-03, 5k08ag000798-03)
- National Institute on Aging (R01AG20729, R01AG020729, K08-AG00798)
- National Institute of Neurological Disorders and Stroke (K08 NS01971, K24 NS02239, K02 NS4311-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- somatic mitochondrial DNA mutations, mitochondrial DNA point mutations, oxidative damage, brain aging, Parkinson's disease, frontal cortex, substantia nigra, transversions, mutational burden, neurodegeneration
- MeSH terms
- Adolescent, Adult, Aged, Aged, 80 and over, Aging, Cell Line, Child, Child, Preschool, DNA Mutational Analysis, DNA, Mitochondrial, Female, Frontal Bone, Humans, Infant, Male, NADH Dehydrogenase, Parkinson Disease, Substantia Nigra, Case-Control Studies, Polymerase Chain Reaction, Point Mutation, Sequence Analysis, DNA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
